Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
2013
Ben Abdelwahed, R., S. Donnou, et al. (2013).
Invest Ophthalmol Vis Sci 54(5): 3657-3665.
2013
Ben Abdelwahed, R., S. Donnou, et al. (2013).
Invest Ophthalmol Vis Sci 54(5): 3657-3665.
